Evidence map›Paper›PMID 23401527›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy.

Andrea Serio, Bilada Bilican, Sami J Barmada, Dale Michael Ando, Chen Zhao, Rick Siller, Karen Burr, Ghazal Haghi, David Story, Agnes Lumi Nishimura and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 219 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
219citing papers in PubMed, 1 pooled it
20.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

219 citing papers in PubMed, 1 synthesis or guideline pooled it, 350 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Clusterin is enriched in plaque-associated astrocytes and localizes to synapses in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

159 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

Andrea SerioEuan MacDonald Centre for Motor Neurone Disease Research, Centre for Neuroregeneration, and Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4UU, United Kingdom.
Bilada Bilican
Sami J Barmada
Dale Michael Ando
Chen Zhao
Rick Siller
Karen Burr
Ghazal Haghi
David Story
Agnes Lumi Nishimura
Monica A Carrasco
Hemali P Phatnani
Carole Shum
Ian Wilmut
Tom Maniatis
Christopher E Shaw
Steven Finkbeiner
Siddharthan Chandran
Medical Research Council · GBColumbia University · USUniversity of Edinburgh · GBGladstone Institutes · USKing's College London · GBMRC Centre for Regenerative Medicine · GBUniversity of California, San Francisco · US

Funding

PREDOCTORAL TRAINING IN BIOMEDICAL SCIENCEST32GM008568 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANSEL, KARL MARK · 1995 to 2019
$6.3M
MECHANISMS OF HUNTINGTIN-INDUCED NEURODEGENERATIONR01NS039074 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI FINKBEINER, STEVEN M · 2000 to 2017
$5.4M
Automated longitudinal single cell analysisR01NS083390 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI FINKBEINER, STEVEN M · 2013 to 2016
$1.6M
Elucidating the Mechanisms Underlying Mutant TDP43-induced NeurodegenerationK08NS072233 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BARMADA, SAMI · 2011 to 2015
$879k
Use of induced pluripotent stem cells to study mechanims of familial and sporadicDP1NS082099 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MANIATIS, THOMAS P · 2012 to 2012
$797k
NCCDPHP CDC HHS 8DP1NS082099-06NIGMS NIH HHS T32 GM008568NINDS NIH HHS DP1 NS082099NINDS NIH HHS K08 NS072233NINDS NIH HHS R01 NS039074NINDS NIH HHS R01 NS083390Wellcome Trust 089701
6 · The paper itself

Abstract

Glial proliferation and activation are associated with disease progression in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia. In this study, we describe a unique platform to address the question of cell autonomy in transactive response DNA-binding protein (TDP-43) proteinopathies. We generated functional astroglia from human induced pluripotent stem cells carrying an ALS-causing TDP-43 mutation and show that mutant astrocytes exhibit increased levels of TDP-43, subcellular mislocalization of TDP-43, and decreased cell survival. We then performed coculture experiments to evaluate the effects of M337V astrocytes on the survival of wild-type and M337V TDP-43 motor neurons, showing that mutant TDP-43 astrocytes do not adversely affect survival of cocultured neurons. These observations reveal a significant and previously unrecognized glial cell-autonomous pathological phenotype associated with a pathogenic mutation in TDP-43 and show that TDP-43 proteinopathies do not display an astrocyte non-cell-autonomous component in cell culture, as previously described for SOD1 ALS. This study highlights the utility of induced pluripotent stem cell-based in vitro disease models to investigate mechanisms of disease in ALS and other TDP-43 proteinopathies.

Indexed as

Amyotrophic Lateral SclerosisAstrocytesInduced Pluripotent Stem CellsMotor NeuronsCell LineCell ProliferationCell SurvivalCoculture TechniquesDNA-Binding ProteinsHumansMaleMiddle AgedMutationDNA-Binding Proteins

Identifiers

PMID23401527
PMCPMC3607024
OpenAlexW1987426179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.